ArticleImmunity2016

HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.

Jon M Steichen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.